Reduced Cardiac Efficiency and Altered Substrate Metabolism Precedes the Onset of Hyperglycemia and Contractile Dysfunction in Two Mouse Models of Insulin Resistance and Obesity
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Hyperglycemia is associated with altered myocardial substrate use, a condition that has been hypothesized to contribute to impaired cardiac performance. The goals of this study were to determine whether changes in cardiac metabolism, gene expression, and function precede or follow the onset of hyperglycemia in two mouse models of obesity, insulin resistance, and diabetes (ob/ob and db/db mice). Ob/ob and db/db mice were studied at 4, 8, and 15 wk of age. Four-week-old mice of both strains were normoglycemic but hyperinsulinemic. Hyperglycemia develops in db/db mice between 4 and 8 wk of age and in ob/ob mice between 8 and 15 wk. In isolated working hearts, rates of glucose oxidation were reduced by 28–37% at 4 wk and declined no further at 15 wk in both strains. Fatty acid oxidation rates and myocardial oxygen consumption were increased in 4-wk-old mice of both strains. Fatty acid oxidation rates progressively increased in db/db mice in parallel with the earlier onset and greater duration of hyperglycemia. In vivo, cardiac catheterization revealed significantly increased left ventricular contractility and relaxation (positive and negative dP/dt) in both strains at 4 wk of age. dP/dt declined over time in db/db mice but remained elevated in ob/ob mice at 15 wk of age. Increased β-myosin heavy chain isoform expression was present in 4-wk-old mice and persisted in 15-wk-old mice. Increased expression of peroxisomal proliferator-activated receptor-α regulated genes was observed only at 15 wk in both strains. These data indicate that altered myocardial substrate use and reduced myocardial efficiency are early abnormalities in the hearts of obese mice and precede the onset of hyperglycemia. Obesity per se does not cause contractile dysfunction in vivo, but loss of the hypercontractile phenotype of obesity and up-regulation of peroxisomal proliferator-activated receptor-α regulated genes occur later and are most pronounced in the presence of longstanding hyperglycemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Animal studies also support a role for T2D in altering myocardial mitochondrial function, such as decreased maximal mitochondrial ATP production despite increased mitochondrial biogenesis, altered palmitate and glucose oxidation, increased ROS emission, and increased mitochondrial uncoupling (117, 118).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [118]
In the citing paper
“Mice with mutations in the leptin receptor (db/db) developed this mutation on the C57BLK/SJ background and develop diabetes as early as 5 wk of age (34).”
From Cardiac remodeling in obesity (2008) · cites this paper as [34]
In the citing paper
“A commonly described feature of most animal models of obesity is increased accumulation of intramyocellular triglycerides in the heart. This has been reported in the hearts of genetic models such as ob/ob and db/db mice (29, 31, 34, 53), Zucker or fa/fa rats (394), and following high-fat feeding (346).”
From Cardiac remodeling in obesity (2008) · cites this paper as [34]
In the citing paper
“For example, while some groups have reported cardiac hypertrophy in hearts of young ob/ob mice (30, 34, 227), others have only observed this phenotype in older animals (23, 24).”
From Cardiac remodeling in obesity (2008) · cites this paper as [34]
In the citing paper
“In contrast, db/db mice that develop a much earlier onset of hyperglycemia exhibited a progressive decline in indices of LV contractility so that by 15 wk of age +dP/dt were equivalent to controls and −dP/dt were reduced (34).”
From Cardiac remodeling in obesity (2008) · cites this paper as [34]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 1×
“Moreover, recent studies in rodents and humans have shown that obesity per se is associated with increased oxidative stress (25).”
BackgroundSuperoxide activates mitochondrial uncoupling proteins
Echtay, K. S., Roussel, D., St-Pierre, J., Jekabsons, M. B., Cadenas, S., Stuart, J. A., Harper, J. A., Roebuck, S. J., Morrison, A., Pickering, S., et al. (2002) · Nature · doi:10.1038/415096a · Cited by 1,382 · cited 1×
“However, recent data suggest that mitochondrial uncoupling can be activated by increased FA flux and even more potently by superoxides (23, 24).”
BackgroundLipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 879
Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome
Alpert, M. A. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200104000-00003 · Cited by 795 · cited 2×
“Many hemodynamic abnormalities have been described in obesity, including elevated cardiac output, altered vascular reactivity, hypertension, and diastolic dysfunction (4).”
BackgroundThe cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 763
Peterson, L. R., Herrero, P., Schechtman, K. B., Racette, S. B., Waggoner, A. D., Kisrieva-Ware, Z., Dence, C., Klein, S., Marsala, J., Meyer, T., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127959.28627.f8 · Cited by 656
Adaptation and Maladaptation of the Heart in Diabetes: Part I: General Concepts
Taegtmeyer, H., McNulty, P., & Young, M. E. (2002) · Circulation · doi:10.1161/01.cir.0000012466.50373.e8 · Cited by 521
Regulation of energy substrate metabolism in the diabetic heart
Stanley, W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00047-3 · Cited by 480 · cited 1×
“Most studies have been performed in models of insulin-deficient (type 1) diabetes (7), and fewer studies have been performed in models of type 2 diabetes.”
BackgroundPathophysiological role of leptin in obesity-related hypertension
Aizawa-Abe, M., Ogawa, Y., Masuzaki, H., Ebihara, K., Satoh, N., Iwai, H., Matsuoka, N., Hayashi, T., Hosoda, K., Inoue, G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8341 · Cited by 477
Adaptation and Maladaptation of the Heart in Diabetes: Part II: Potential Mechanisms
Young, M. E., McNulty, P., & Taegtmeyer, H. (2002) · Circulation · doi:10.1161/01.cir.0000012467.61045.87 · Cited by 466
Izumo, S., Lompré, A. M., Matsuoka, R., Koren, G., Schwartz, K., Nadal-Ginard, B., & Mahdavi, V (1987) · Journal of Clinical Investigation · doi:10.1172/jci112908 · Cited by 447
Mazumder, P. K., O’Neill, B. T., Roberts, M. W., Buchanan, J., Yun, U. J., Cooksey, R. C., Boudina, S., & Abel, E. D. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2366 · Cited by 437
Self-citationUnloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy
Depre, C., Shipley, G. L., Chen, W., Han, Q., Doenst, T., Moore, M. L., Stepkowski, S., Davies, P. J. A., & Taegtmeyer, H. (1998) · Nature Medicine · doi:10.1038/3253 · Cited by 423
Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice
Belke, D. D., Larsen, T. S., Gibbs, E. M., & Severson, D. L. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1104 · Cited by 401
Superoxide Activates Mitochondrial Uncoupling Protein 2 from the Matrix Side
Echtay, K. S., Murphy, M. P., Smith, R. A. J., Talbot, D. A., & Brand, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208262200 · Cited by 388 · cited 1×
“However, recent data suggest that mitochondrial uncoupling can be activated by increased FA flux and even more potently by superoxides (23, 24).”
BackgroundBelke, D. D., Betuing, S., Tuttle, M. J., Graveleau, C., Young, M. E., Pham, M., Zhang, D., Cooksey, R. C., McClain, D. A., Litwin, S. E., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13946 · Cited by 376
Self-citationCardiac Lipid Accumulation Associated with Diastolic Dysfunction in Obese Mice
Christoffersen, C., Bollano, E., Lindegaard, M. L. S., Bartels, E. D., Goetze, J. P., Andersen, C. B., & Nielsen, L. B. (2003) · Endocrinology · doi:10.1210/en.2003-0242 · Cited by 375
Belke, D. D., Betuing, S., Tuttle, M. J., Graveleau, C., Young, M. E., Pham, M., Zhang, D., Cooksey, R. C., McClain, D. A., Litwin, S. E., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213946 · Cited by 330
Self-citationPrevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology
Howard, B. V., Rodriguez, B. L., Bennett, P. H., Harris, M. I., Hamman, R., Kuller, L. H., Pearson, T. A., & Wylie-Rosett, J. (2002) · Circulation · doi:10.1161/01.cir.0000013953.41667.09 · Cited by 308
Impaired Long-Chain Fatty Acid Oxidation and Contractile Dysfunction in the Obese Zucker Rat Heart
Young, M. E., Guthrie, P. H., Razeghi, P., Leighton, B., Abbasi, S., Patil, S., Youker, K. A., & Taegtmeyer, H. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2587 · Cited by 295
Grundy, S. M., Howard, B., Smith, S., Eckel, R., Redberg, R., & Bonow, R. O. (2002) · Circulation · doi:10.1161/01.cir.0000013952.86046.dd · Cited by 283
Aasum, E., Hafstad, A. D., Severson, D. L., & Larsen, T. S. (2003) · Diabetes · doi:10.2337/diabetes.52.2.434 · Cited by 280 · cited 2×
“(10) reported that 6-wk-old db/db mice did not exhibit elevated levels of glucose in random-fed animals.”
BackgroundLuiken, J. J. F. P., Koonen, D. P. Y., Willems, J., Zorzano, A., Becker, C., Fischer, Y., Tandon, N. N., van der Vusse, G. J., Bonen, A., & Glatz, J. F. C. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3113 · Cited by 260
Eckel, R. H., Barouch, W. W., & Ershow, A. G. (2002) · Circulation · doi:10.1161/01.cir.0000017823.53114.4c · Cited by 258
Hu, P., Zhang, D., Swenson, L., Chakrabarti, G., Abel, E. D., & Litwin, S. E. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00108.2003 · Cited by 245
Self-citationInfluence of diabetes mellitus on heart failure risk and outcome
Bauters, C., Lamblin, N., Mc Fadden, E. P., Van Belle, E., Millaire, A., & de Groote, P. (2003) · Cardiovascular Diabetology · doi:10.1186/1475-2840-2-1 · Cited by 216
Coort, S. L. M., Hasselbaink, D. M., Koonen, D. P. Y., Willems, J., Coumans, W. A., Chabowski, A., van der Vusse, G. J., Bonen, A., Glatz, J. F. C., & Luiken, J. J. F. P. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1655 · Cited by 202
Developmental and hormonal regulation of sarcomeric myosin heavy chain gene family.
Mahdavi, V, Izumo, S., & Nadal-Ginard, B. (1987) · Circulation Research · doi:10.1161/01.res.60.6.804 · Cited by 198
Depre, C., Young, M. E., Ying, J., Ahuja, H. S., Han, Q., Garza, N., Davies, P. J., & Taegtmeyer, H. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1139 · Cited by 194
Alterations of the Circadian Clock in the Heart by Streptozotocin-induced Diabetes
Young, M. E., Wilson, C. R., Razeghi, P., Guthrie, P. H., & Taegtmeyer, H. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1504 · Cited by 166
Bezaire, V., Spriet, L. L., Campbell, S., Sabet, N., Gerrits, M., Bonen, A., & Harper, M. ‐. (2005) · The FASEB Journal · doi:10.1096/fj.04-2765fje · Cited by 132
Cardiac carbohydrate metabolism in Zucker diabetic fatty rats
Chatham, J. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00399-1 · Cited by 118
Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm
Chabowski, A., Coort, S. L. M., Calles-Escandon, J., Tandon, N. N., Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00573.2003 · Cited by 110
Cardiovascular effects of leptin and orexins
Shirasaka, T., Takasaki, M., & Kannan, H. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00359.2002 · Cited by 82
Cardiac Dysfunction Caused by Myocardium-Specific Expression of a Mutant Thyroid Hormone Receptor
Pazos-Moura, C., Abel, E. D., Boers, M.-E., Moura, E., Hampton, T. G., Wang, J., Morgan, J. P., & Wondisford, F. E. (2000) · Circulation Research · doi:10.1161/01.res.86.6.700 · Cited by 46
Self-citationCardiac Abnormalities Associated with Morbid Obesity
Herrera, M. F., Oseguera, J., Gamino, R., Gutiérrez‐Cirlos, C., Vargas-Vorácková, F., González‐Barranco, J., & Rull, J. A. (1998) · World Journal of Surgery · doi:10.1007/s002689900505 · Cited by 9
Cited by
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
Diabetic Cardiomyopathy Revisited
Boudina, S., & Abel, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.679597 · Cited by 1,543
Self-citationCardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,373
Self-citationMolecular mechanisms of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2014) · Diabetologia · doi:10.1007/s00125-014-3171-6 · Cited by 903
Self-citationTan, Y., Zhang, Z., Zheng, C., Wintergerst, K. A., Keller, B. B., & Cai, L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0339-2 · Cited by 835
Metadata
- Authors
- Buchanan, J., Mazumder, P. K., Hu, P., Chakrabarti, G., Roberts, M. W., Yun, U. J., Cooksey, R. C., Litwin, S. E., & Abel, E. D.
- Affiliations
- University of Utah (US)
- Corresponding author
- Abel, E. Dale
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-12-01
- Volume
- 146
- Issue
- 12
- Pages
- 5341-5349
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2114671826
- Cited by
- 555
- References
- 37
- Citations by year
- 2026: 10 · 2025: 29 · 2024: 19 · 2023: 26 · 2022: 24 · 2021: 24 · 2020: 28 · 2019: 22 · 2018: 33 · 2017: 35 · 2016: 32 · 2015: 38 · 2014: 39 · 2013: 30 · 2012: 39
- FWCI
- 11.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- American Heart Association
- National Institutes of Health
- U.S. Public Health Service (U01-70525)
- National Heart, Lung, and Blood Institute (HL 73167, R01HL073167)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- myocardial substrate metabolism, hyperglycemia, insulin resistance, obesity, cardiac contractile dysfunction, glucose oxidation, fatty acid oxidation, myocardial oxygen consumption, ob/ob mice, db/db mice, diabetes mellitus, left ventricular function
- MeSH terms
- Animals, Diabetes Mellitus, Heart, Hyperglycemia, Insulin Resistance, Male, Mice, Inbred C57BL, Myocardial Contraction, Myocardium, Obesity, Oxygen Consumption, Gene Expression, Myosin Heavy Chains, PPAR alpha, Diabetes Complications, Mice, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.